What is an Informed Consent Form (ICF)?
What is an Informed Consent Form?
An Informed Consent Form (ICF) is a formal document used in clinical trials that ensures participants are fully informed about the study they’re being asked to join. It outlines the purpose, procedures, risks, benefits, and rights of the participant before they agree to take part.
The ICF outlines the purpose of the trial, what participation involves, possible risks and benefits, and the rights of participants, including the right to withdraw at any time. In short, it gives people the information they need to make a voluntary and informed decision.
Participants aren’t simply signing a document; they’re agreeing to contribute to science based on clear, transparent, and understandable information. Without informed consent, a clinical trial cannot ethically or legally proceed.How is the ICF used?
The informed consent process begins before a participant joins a clinical trial. Here’s how it usually works in a real-world setting:
Initial discussion: A research team member (often a Clinical Research Coordinator) explains the study in detail using the ICF as a guide. This is often a face-to-face conversation, giving the participant a chance to ask questions.
Review and reflection: The participant is given time to review the ICF independently, consult with family or a physician, and reflect on their decision. Signing the form: If they agree to join, the participant signs the ICF — usually along with a witness or site staff member. Ongoing updates: If anything about the study changes (e.g., new risks are discovered), participants are provided with an updated ICF and asked to re-consent. ICFs aren’t just “one and done.” They’re living documents that evolve alongside the clinical trial. Keeping versions accurate, current, and properly signed is critical, both ethically and legally.What does an ICF typically include?
While the format can vary by country, sponsor, or study type, a standard ICF generally includes:
Study purpose – An overview of the trial; what condition or disease it's targeting, why the research is being conducted, and how the results might be used.Procedures – A breakdown of what participation involves, such as how often the participant will need to attend site visits, what procedures (blood tests, scans, questionnaires) will be done, and how long the study will last.
Risks and side effects – A clear explanation of any known or possible risks, including side effects of study drugs or discomfort from procedures.
Benefits – An honest assessment of whether the participant might benefit medically - though most ICFs also clarify that there may be no direct benefit.
Alternatives – A statement outlining other available treatments or procedures outside of the clinical trial.
Data Privacy & Confidentiality – Information on how the participant’s personal data and health records will be collected, stored, and protected.
Voluntary participation – A reminder that participation is entirely voluntary, and that the participant can leave the study at any time, without penalty or loss of medical care.
Contact information – Details on who to contact with questions, emergencies, or concerns - usually the Principal Investigator or site staff.
Why is the ICF such an important document?
The primary purpose of the ICF is to protect the autonomy and safety of participants. Clinical research often involves investigational products or new procedures, which may carry unknown risks. It’s essential that participants are aware of these risks along with any potential benefits so they can decide whether taking part is right for them.
Here’s why the ICF is so important:
It ensures transparency: People deserve to know exactly what they’re getting into when they participate in a study — from the number of site visits required to how their data will be used. It reinforces ethics: Informed consent is a core principle of research ethics and human rights. The ICF ensures participants have the information and freedom to choose. It satisfies regulatory requirements: Global regulatory bodies like the FDA, EMA, and ICH-GCP require a robust informed consent process to approve and monitor clinical trials. It builds trust: A well-structured and compassionate informed consent process helps foster trust between researchers and participants - something that’s critical for participant retention and long-term engagement.Common Challenges
While the purpose of ICFs is clear, managing them in practice can be complex, especially in global, multi-site trials. Here are a few common challenges professionals in clinical research may face:
Length and language – ICFs can be overly long or filled with medical jargon, which can confuse participants or lead to poor comprehension. Striking a balance between completeness and readability is key.
Version control – As protocols change, so too must the ICF. Ensuring every site is using the correct version and has correctly re-consented existing participants requires strong document management and communication.
Regulatory variation – Every country and sometimes individual ethics committees may have different requirements for ICF content, translations, or formatting. Ensuring global compliance can be a time-consuming process.
Who works with Informed Consent Forms?
ICFs touch nearly every part of the clinical trial team. If you're considering a job in clinical research there's a high chance you'll encounter ICFs in some capacity. Here's how different roles interact with informed consent:
Clinical Research Coordinators (CRC) CRCs are often the ones who present the ICF to participants, answer questions, and obtain signatures. They also ensure proper documentation is maintained throughout the study.
Clinical Research Associates (CRA) CRAs don’t obtain consent directly, but they monitor the consent process to ensure it complies with GCP, protocol, and regulatory requirements. They check ICF documentation during site visits and audits.
Regulatory Affairs Specialists These professionals are responsible for submitting ICFs for review to ethics committees and Institutional Review Boards (IRBs), ensuring all language and content meet local and international regulatory requirements.
Clinical Trial Assistant (CTA) CTAs help manage ICF version control, filing, and documentation tracking, especially in larger studies where accuracy and audit readiness are critical.
Career Advice
If you’re exploring jobs in clinical research, understanding the role and significance of ICFs gives you a real advantage. Whether you’re interviewing for a CRA role or applying as a Clinical Trial Assistant, being familiar with informed consent shows:
- Familiarity with core regulatory principles
- Attention to detail and ethics
- Knowledge of patient engagement best practices
Many employers look for candidates who already have a grasp of core clinical trial concepts - the ICF is one of the most fundamental.
Conclusion
The Informed Consent Form might seem like just another part of the paperwork behind clinical trials but in reality, it’s an essential document for transparency, ethics, and trust. For those pursuing careers in clinical research, learning the ins and outs of ICFs is not just a technical requirement, it's a meaningful step toward putting patients first.
Whether you're considering a CRC role at a clinical site or looking to work as a CRA monitoring global trials, understanding informed consent is key to building a career that contributes to high-quality, patient-centric research.
If you're interested in building a career in clinical research, view our current clinical vacancies today.
Sign up for post alerts
ICON & You
The potential of together.
Careers that improve the lives of patients, our clients and each other. Are you ready to make a difference?
View jobsRelated jobs at ICON
Salary
Location
Texas
Location
Texas
Remote Working
Remote
Business Area
ICON Strategic Solutions (FSP)
Job Categories
Clinical Monitoring
Job Type
Permanent
Description
As a Senior CRA at ICON Plc, you will oversee and manage clinical trial activities to ensure they are conducted according to protocol, regulatory requirements, and industry standards.What You Will Do:
Reference
JR155603
Expiry date
01/01/0001
Author
Brandon PupekAuthor
Brandon PupekSalary
Location
Chicago, IL
Location
Missouri
Michigan
Chicago, IL
Kansas City, MO
Remote Working
Remote
Business Area
ICON Strategic Solutions (FSP)
Job Categories
Clinical Monitoring
Job Type
Permanent
Description
As a Senior CRA at ICON Plc, you will oversee and manage clinical trial activities to ensure they are conducted according to protocol, regulatory requirements, and industry standards.What You Will Do:
Reference
JR155606
Expiry date
01/01/0001
Author
Brandon PupekAuthor
Brandon PupekSalary
Location
New York
Location
New York
New Jersey
Boston, MA
Philadelphia, PA
Remote Working
Remote
Business Area
ICON Strategic Solutions (FSP)
Job Categories
Clinical Monitoring
Job Type
Permanent
Description
As a Senior CRA at ICON Plc, you will oversee and manage clinical trial activities to ensure they are conducted according to protocol, regulatory requirements, and industry standards.What You Will Do:
Reference
JR155605
Expiry date
01/01/0001
Author
Brandon PupekAuthor
Brandon PupekSalary
Location
Brazil, Sao Paulo
Location
Sao Paulo
Remote Working
Remote
Business Area
ICON Strategic Solutions (FSP)
Job Categories
Clinical Monitoring
Job Type
Permanent
Description
As a CRA I at ICON, you will contribute to our clinical trial operations function, working collaboratively to deliver high-quality outcomes across our clinical programmes.What You Will Do:Your role wi
Reference
JR153382
Expiry date
01/01/0001
Author
Simone ChanAuthor
Simone ChanRelated stories
Teaser label
Our PeopleContent type
BlogsPublish date
07/06/2026
Summary
Meet the CRA helping shape a new partnership Ask Rebeca Rojas Hernández what her dad tells people she does for a living and she can't help but smile. "He proudly tells everyone that I visit clinic
Teaser label
Our PeopleContent type
BlogsPublish date
07/06/2026
Summary
Inside the Role of a Senior CRA: Diego's Clinical Research Career at ICON Ask Diego Prieto what he does for a living and his answer is refreshingly simple. "I usually tell people I work on trial
Teaser label
Inside ICONContent type
BlogsPublish date
07/06/2026
Summary
Why returning to ICON was the right career move for Albert Bekfi Sometimes the next step in your career means moving on. Sometimes it means coming back. For Albert Bekfi, Vice President, Pharmacov
Recently viewed jobs
Impactful work. Meaningful careers. Quality rewards.
At ICON, our employees are our greatest strength. That’s why we are committed to empowering you to live your best life, both inside and outside of work. Whether your ambition is lead a global team, become a deep scientific or technical expert, work in-house with our customers or gain experience in a variety of different ICON functions, we will support you in realising your full potential. Learn more about Our Culture at ICON